|Bid||0.59 x 0|
|Ask||0.61 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canada on Track as First G7 Nation to Federally Legalize Cannabis Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company”) is pleased to raise its hand in support of the Canadian’s Senate approval of the legalization of adult recreational cannabis use, which could occur within eight to twelve weeks.“The Senate overwhelmingly voted in favour of the revised bill from the House of Commons which should create a fully federally legal cannabis program for Canada within eight to twelve weeks”.” Said Evitrade CEO CK Cheung. ...
Vancouver, British Columbia, June 20, 2018-- EVITRADE Health Systems Corp. is pleased to raise its hand in support of the Canadian’ s Senate approval of the legalization of adult recreational cannabis ...
EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company” or “Evitrade”) is a Canadian company but has taken a keen interest of late in American legislative politics. President Donald Trump has indicated he will “probably” back the bill, greatly increasing its odds of passage. Not because it legalizes cannabis throughout the United States – it doesn’t.
EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company”) announces that it has signed the Definitive Agreement with Cantech Molecular Research Inc. (“Cantech”). Among the many progressive capabilities EVA will gain with the Cantech acquisition is the ability to produce true homozygotic plants with a highly select and consistent set of traits.
Investorideas.com, a global news source and investor resource covering cannabis stocks issues a sector news alert on Canadian cannabis stocks introducing natural and organic alternatives to key health issues using cannabinoids. A global revolution is taking place in healthcare, life sciences and the food and beverage industry with applications including treatment of anxiety and sleep disorders, pain management, drug delivery and food supplements. The global landscape is changing so rapidly that in some instances, cannabis is now taking on traditional healthcare at par. Troy Dayton, CEO and Founder of the Arcview Group, told Investor Ideas at the recently held Arcview Investor Forum in Vancouver B.C., “What’s happening in Germany is very interesting.
EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company”) announces that it has embarked on a program to utilize its contacts in the blockchain technology space to marry the security of blockchain technology with the Company’s interest in the international industrial Hemp trade. The Company has signed a Letter of Intent with Veri-Medical Systems (“VeriMed” or the “Company”) to potentially acquire the Company which is involved in developing a blockchain based “seed-to-sale” protocol focussed on enhancing the integrity of the sale of Hemp based products such as cannabidiol (“CBD”). “We are very excited to be standing at the cross-road of being able to combine the security that block-chain technologies offer with the bright future of Hemp based protocols and products” said C.K., CEO for Evitrade Health.